UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023

Rhea-AI Summary

Emergent BioSolutions Inc. has rescheduled its conference call to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for full year 2023. The call will now take place on Wednesday, November 8, at 5:00 pm eastern time. Participants can access the call via webcast or telephone.

GAITHERSBURG, Md., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) has rescheduled its conference call to Wednesday, November 8, at 5:00 pm eastern time to discuss the financial results for the third quarter of 2023, recent business developments, and financial outlook for full year 2023. The call will no longer take place on November 2, 2023.

Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

FAQ

When is Emergent BioSolutions Inc.'s conference call to discuss the financial results for the third quarter of 2023?

The conference call is scheduled for Wednesday, November 8, at 5:00 pm eastern time.

Where can participants access the conference call?

Participants can access the call via webcast from the Investors page of Emergent's website or through telephone.

How can participants join the conference call via telephone?

Participants need to register in advance at the provided link to receive a confirmation email with the dial-in number, passcode, and registrant ID.

Can the conference call be accessed after it has taken place?

Yes, a replay of the call can be accessed from the Investors page of Emergent's website.